Humana ABLTS:0RF7 +1.34%58 EV-to-FCF is 10.21 as of Jul. 02, 2026, which is 2% above its 10-year median of 10.05. GuruFocus rates LTS:0RF7 with a GF Score™ of 58/100 and a GF Value™ of kr35.93 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Humana AB ranks better than 69.21% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Humana AB's Enterprise Value is kr7,364 Mil.
Humana AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr721 Mil. Therefore, Humana AB's EV-to-FCF for today is 10.21.
The historical rank and industry rank for Humana AB's EV-to-FCF or its related term are showing as below:
LTS:0RF7'
s EV-to-FCF Range Over the Past 10 Years
Min: -38.46 Med: 10.05 Max: 28.73
Current: 10.21
During the past 13 years, the highest EV-to-FCF of Humana AB was 28.73. The lowest was -38.46. And the median was 10.05.
LTS:0RF7's EV-to-FCF is ranked better than 69.21% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.57
vs LTS:0RF7: 10.21
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Humana AB's share price for today is kr64.30.
Humana AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Humana AB EV-to-FCF Related Terms
Humana AB EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Humana AB's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Humana AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana AB EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Humana AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Humana AB's EV-to-FCF falls into.
Humana AB's current Enterprise Value is kr7,364 Mil.
Humana AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr721 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humana AB (LTS:0RF7) has a EV-to-FCF of 10.21 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Humana AB and its competitors. This is near median its historical median of 10.05. According to the industry distribution chart, Humana AB ranks #125 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 30.8%.
Is Humana AB's EV-to-FCF too high?
Humana AB's current EV-to-FCF of 10.21 is near median its 10-year median of 10.05. The Healthcare Providers & Services industry median EV-to-FCF is 17.57. Humana AB's value of 10.21 is 41.9% below this industry median. Based on the distribution chart, Humana AB ranks #125 out of 406 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Humana AB has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Humana AB's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Humana AB ranks #125 out of 406 companies for EV-to-FCF. This puts Humana AB in the upper half of its industry. The industry median EV-to-FCF is 17.57. Humana AB's value of 10.21 is 41.9% below this benchmark. While the company's 10-year median is 10.05 vs. the industry median of 17.57, Humana AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.57, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humana AB's current EV-to-FCF of 10.21 is 41.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Humana AB and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana AB's current EV-to-FCF is 10.21, which is near median its own 10-year median of 10.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana AB stock overvalued right now?
Based on GuruFocus' analysis, Humana AB (LTS:0RF7) is currently considered Significantly Overvalued. The stock's GF Value™ is kr35.93, compared to a current price of kr64.30 — trading 79% above its estimated fair value. The current EV-to-FCF is 10.21, which is near median its 10-year median of 10.05 and 41.9% below the Healthcare Providers & Services industry median of 17.57. Humana AB's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Humana AB (LTS:0RF7), the current EV-to-FCF is 10.21 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana AB (LTS:0RF7) Overvalued in 2026?
Based on GuruFocus' analysis, Humana AB stock appears to be overvalued.
The current stock price of kr64.30 is trading 79% above its estimated GF Value™ of kr35.93.
GuruFocus considers Humana AB to be Significantly Overvalued.
Key valuation signals for LTS:0RF7:
EV-to-FCF: 10.21 (near median its 10-year median of 10.05)
GF Value™: kr35.93 vs. price of kr64.30 (79% above fair value)
Industry Position: 41.9% below the Healthcare Providers & Services median (#125 of 406)
No single metric tells the full story. See the LTS:0RF7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana AB is a provider of private care services in the Nordic region. The company offers services including individual and family care, personal assistance, elderly care and housing with special services. Geographically, the company operates in Sweden, Norway, Finland, Denmark, and others. It derives maximum revenue from Sweden.
58GF Score
Get the complete analysis for LTS:0RF7
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RF7 has been successfully added to your 
